Press Release

All news, publications, and updates from Seek Labs.

Press Release, Featured, Home Page

June 8, 2026

Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery

Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery The company’s comprehensive viral target atlas is designed to move development from reactive crisis response toward proactive, pre-identified genomic vulnerability mapping June 8, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable…
Diagnostics, Featured, Home Page, News, Press Release

May 7, 2026

Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing

Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing Newly issued patent covers foundational amplification chemistry designed to support sensitive molecular detection without thermal cycling or centralized laboratory infrastructure May 7, 2026 SALT LAKE CITY, UT (Business Wire) — Seek Labs, a private TechBio company building programmable platforms to decode,…
Featured, Home Page, News, Press Release, Therapeutics

February 17, 2026

Seek Labs Awarded $2M USDA Grant for CRISPR Avian Flu Therapeutic

Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based, Mutation-Resistant Therapeutic to Combat Avian Flu in Partnership with Canadian Food Inspection Agency USDA grant is part of a broader federal push to find innovative solutions to fight the highly infectious avian flu (HPAI), which continues to spread globally and impact egg and poultry…
Home Page, Papers, Press Release

December 8, 2025

Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats

Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats December 8, 2025 Read the full open-access review in Viruses Seek Labs today announced the publication of a new editorial review in Viruses (MDPI), authored by Alison O’Mahony, Senior VP of Research, and Douglas P. Gladue, VP…
Papers, Press Release

November 17, 2025

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever November 17, 2025 SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI),…
Featured, News, Press Release, Therapeutics

October 21, 2025

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™ October 21, 2025 Salt Lake City, UT (Business Wire)–Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease Atlas™ to include multiple hemorrhagic fever viruses.…
Featured, News, Press Release, Therapeutics

October 7, 2025

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ October 7, 2025 BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family. Early in vitro testing of the BioSeeker-developed therapeutic construct achieved up to 90% viral knockdown in a vaccinia virus model, laying the…

Stay connected

Follow the work as it unfolds.

Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.

Press Release

Seek Labs Maps 25/25 Viral Families through BioSeeker, Advancing a New Model for Sequence-Directed Antiviral Discovery

Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing

Seek Labs Awarded $2M USDA Grant for CRISPR Avian Flu Therapeutic

Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™

Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™

Follow the work as it unfolds.